Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.
Ready Steady Cut on MSN
'Brilliant Minds' Season 2, Episode 3 Recap - A Very Good Case Takes Centre Stage
Sometimes, Brilliant Minds only has a so-so case of the week to justify focusing primarily on the characters and their ...
Actress, singer and makeup mogul Selena Gomez has been candid about her experience of living with lupus. Since 2015, Gomez ...
Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of ...
Objective No studies have investigated the incidence and correlation of scarring and dyspigmentation across all cutaneous ...
Objectives Despite the clinical significance of neuropsychiatric systemic lupus erythematosus (NPSLE), which is a severe ...
Introduction SLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, ...
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...
Objective Patients with systemic lupus erythematosus (SLE) commonly develop lupus nephritis (LN), the most frequent severe ...
Children and teenagers are more vulnerable to meningitis than adults because their immune systems are still developing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback